Stockreport

OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors
PDF OptimizeRx Corporation - Q4 revenue of $32.2 million - Q4 gross profit increased 9% year-over-year to $24.1 million - Q4 net income and adjusted EBITDA hit record [Read more]